Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
Jack F ShernJoanna L SelfeElisa IzquierdoRajesh PatidarHsien-Chao ChouYoung K SongMarielle E YoheSivasish SindiriJun S WeiXinyu WenErin R RudzinskiDonald A BarkauskasTammy LoDavid C HallCorinne M LinardicDebbie HughesSabri JamalMeriel JenneyJulia C ChisholmRebecca BrownKristine JonesBelynda D HicksPaola AngeliniSally L GeorgeLouis CheslerMichael HubankAnna KelseySusanne Andrea GatzStephen X SkapekDouglas S HawkinsJanet M ShipleyJaved KhanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
This is the largest genomic characterization of clinically annotated rhabdomyosarcoma tumors to date and provides prognostic genetic features that refine risk stratification and will be incorporated into prospective trials.